Trial reportScientific reports2026
The role of probiotics in nutritional intake and clinical outcomes of critically Ill children with severe sepsis: a double-blind, placebo-controlled trial.
Trial report in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
We aimed to investigate the effect of probiotic supplementation on nutritional status and sepsis-associated nutritional complications in children with severe sepsis. In this study, 47 critically ill children with sepsis were randomly assigned to either the probiotic or the placebo group. The patients in the probiotic group received a sachet of probiotic twice daily, and those in the placebo group received corn starch daily for 1 week. The children in the probiotic group had a lower incidence of delayed start of nutrition (46% vs. 77%, P = 0.03) and sepsis-related gastrointestinal complications (9% vs. 36%, P = 0.03), especially for constipation (P = 0.02) and abdominal distension (P = 0.04) compared to the placebo group. Moreover, calorie intake achievement was shorter in the probiotic group than the placebo group (2.7 ± 0.8 days vs. 3.8 ± 1.0 days, P < 0.001). The probiotic group had remarkably higher mean calorie (44.3 ± 7.6 vs. 33.1 ± 10.5 kcal/kg daily, P = 0.01) and some micronutrient intake (P < 0.05). A significant improvement in Z-score for BMI in children > 2 years (0.35 ± 0.13 vs. -0.11 ± 0.18, P = 0.008) was observed after intervention. Probiotic administration may decrease the length of calorie goal achievement, delayed nutrition, and nutritional intolerance in children with sepsis. Well-designed multicenter clinical studies with defined combinations of probiotics and appropriate study lengths are necessary in this field.Trial Registration: Registered at the Iranian Registry of Clinical Trials (www.irct.ir) with the number IRCT20170202032367N10. Registration Date 15/08/2023.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.